UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypoxia Signaling in Cancer: From Basics to Clinical Practice

Pathology oncology research, 2021-05, Vol.27, p.1609802-1609802

2021

Volltextzugriff (PDF)

Tumor-specific inhibitory action of decorin on different hepatoma cell lines

Cellular signalling, 2019-10, Vol.62, p.109354-109354, Article 109354

2019

Volltextzugriff (PDF)

3D bioprinting and the revolution in experimental cancer model systems-A review of developing new models and experiences with in vitro 3D bioprinted breast cancer tissue-mimetic structures

Pathology oncology research, 2023-02, Vol.29, p.1610996

2023

Volltextzugriff (PDF)

RICTOR amplification is associated with Rictor membrane staining and does not correlate with PD-L1 expression in lung squamous cell carcinoma

Pathology oncology research, 2024, Vol.30, p.1611593-1611593

2024

Volltextzugriff (PDF)

Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas

British journal of cancer, 2024-04, Vol.130 (7), p.1119-1130

2024

Volltextzugriff (PDF)

Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

Cancer cell international, 2018-12, Vol.18 (1), p.211-211, Article 211

2018

Volltextzugriff (PDF)

Expression of Certain Leukemia/Lymphoma Related microRNAs and its Correlation with Prognosis in Childhood Acute Lymphoblastic Leukemia

Pathology oncology research, 2015-07, Vol.21 (3), p.597-604

2015

Volltextzugriff (PDF)

S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression

Cells (Basel, Switzerland), 2020-08, Vol.9 (8), p.1864

2020

Volltextzugriff (PDF)

Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma

Cancers, 2020-07, Vol.12 (7), p.1947

2020

Volltextzugriff (PDF)

Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations

Cancer and metastasis reviews, 2021-12, Vol.40 (4), p.1141-1157

2021

Volltextzugriff (PDF)

The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells

Pathology oncology research, 2019-10, Vol.25 (4), p.1379-1386

2019

Volltextzugriff (PDF)

The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues

Cancer and metastasis reviews, 2021-12, Vol.40 (4), p.989-1033

2021

Volltextzugriff (PDF)

Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting

International journal of molecular sciences, 2022-07, Vol.23 (13), p.7444

2022

Volltextzugriff (PDF)

Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells

International journal of molecular sciences, 2021-08, Vol.22 (15), p.8019

2021

Volltextzugriff (PDF)

Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response

PloS one, 2022-05, Vol.17 (5), p.e0268217

2022

Volltextzugriff (PDF)

Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation

Tumor biology, 2016-10, Vol.37 (10), p.13695-13704

2016

Volltextzugriff (PDF)

Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics

International journal of molecular sciences, 2022-09, Vol.23 (18), p.10587

2022

Volltextzugriff (PDF)

Novel RICTOR amplification harbouring entities: FISH validation of RICTOR amplification in tumour tissue after next-generation sequencing

Scientific reports, 2023-11, Vol.13 (1), p.19610-19610, Article 19610

2023

Volltextzugriff (PDF)

mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies

Pathology oncology research, 2024-03, Vol.30, p.1611643-1611643

2024

Volltextzugriff (PDF)

Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy Response

Pathology oncology research, 2022-05, Vol.28, p.1610322-1610322

2022

Volltextzugriff (PDF)

Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells

Pathology oncology research, 2020-01, Vol.26 (1), p.23-33

2020

Volltextzugriff (PDF)

GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas

Journal of experimental & clinical cancer research, 2018-11, Vol.37 (1), p.271-271, Article 271

2018

Volltextzugriff (PDF)

Promoter Hypomethylation and Increased Expression of the Long Non-coding RNA LINC00152 Support Colorectal Carcinogenesis

Pathology oncology research, 2020-10, Vol.26 (4), p.2209-2223

2020

Volltextzugriff (PDF)

Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells

Journal of experimental & clinical cancer research, 2017-06, Vol.36 (1), p.74-74, Article 74

2017

Volltextzugriff (PDF)

In Situ Metabolic Characterisation of Breast Cancer and Its Potential Impact on Therapy

Cancers, 2020-09, Vol.12 (9), p.2492

2020

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(36)
Buchkapitel
(1)

Sprache

Englisch
(36)
Ungarisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypoxia Signaling in Cancer: From Basics to Clinical Practice

Tumor-specific inhibitory action of decorin on different hepatoma cell lines

3D bioprinting and the revolution in experimental cancer model systems-A review of developing new models and experiences with in vitro 3D bioprinted breast cancer tissue-mimetic structures

RICTOR amplification is associated with Rictor membrane staining and does not correlate with PD-L1 expression in lung squamous cell carcinoma

Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas

Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

Expression of Certain Leukemia/Lymphoma Related microRNAs and its Correlation with Prognosis in Childhood Acute Lymphoblastic Leukemia

S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression

Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma

Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations

The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells

The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues

Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting

Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells

Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response

Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation

Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics

Novel RICTOR amplification harbouring entities: FISH validation of RICTOR amplification in tumour tissue after next-generation sequencing

mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies

Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy Response

Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells

GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas

Promoter Hypomethylation and Increased Expression of the Long Non-coding RNA LINC00152 Support Colorectal Carcinogenesis

Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells

In Situ Metabolic Characterisation of Breast Cancer and Its Potential Impact on Therapy

Suchergebnisse filtern